Pharma

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

Aisling Capital is a leading investment firm focused on healthcare. They invest across various stages and structures in companies developing and commercializing innovative healthcare products and services. Their team's expertise allows them to provide strategic guidance and capital to portfolio companies.

Amplitude Ventures is a savvy investor and proven company builder focused on bringing exceptional healthcare innovations to market. They work with healthcare entrepreneurs to deliver life-changing therapies to patients while providing superior value to investors. Their expertise lies in precision medicine, and they have a strong track record of supporting companies from early stages to IPO.

Aperture Venture Partners is a healthcare-focused investment firm committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors. Our partners have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.

Axil Capital is a venture capital firm specializing in biomedical and healthcare technology investments. They focus on supporting the growth of early-stage ventures and leveraging their global network to create synergies between the Japanese and global biotech ecosystems. Their investments span the full spectrum of the life science industry, from seed to crossover rounds.

Columbus Venture Partners invests in early-stage opportunities in the life science industry.

Correlation Ventures is an early-stage venture capital firm with a data-driven approach. They focus on making rapid investment decisions and building strong relationships with portfolio companies to support their growth. Their efficient process and broad network help startups find the right investors and partners.

DAG Ventures is a mid-stage venture capital partnership focused on providing service-oriented support to visionary entrepreneurs and early-stage VCs. They lead mid-stage and growth financing rounds into promising portfolio companies. Their investment model emphasizes differentiation through superior service to LPs, portfolio companies, and early-stage VC partnerships.

Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage and growth-stage healthcare companies. They focus on companies with revolutionary technologies and strong market presence. Founded in 2012, Decheng has over $2 billion in capital.

Firstime Ventures invests in companies building a sustainable and accessible future. They focus on entrepreneurs with impactful products and clear business models, addressing urgent challenges like climate change and accessible healthcare. Their investment strategy aligns with the United Nations Sustainable Development Goals.

Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies.

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.